Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × INCB039110 × Clear all

NCT03425006 2023-09-13

Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer

Phase 2 Terminated

23 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung